Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Instagram Outage Disrupts Thousands of U.S. Users 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Tabletop particle accelerator could transform medicine and materials science 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
